🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

FBI official says foreign hackers have targeted COVID-19 research

Published 2020-04-16, 07:12 p/m

By Raphael Satter and Christopher Bing

WASHINGTON (Reuters) - A senior cybersecurity official with the Federal Bureau of Investigation said on Thursday that foreign government hackers have broken into companies conducting research into treatments for COVID-19, the respiratory illness caused by the coronavirus.

FBI Deputy Assistant Director Tonya Ugoretz told participants in an online panel discussion hosted by the Aspen Institute that the bureau had recently seen state-backed hackers poking around a series of healthcare and research institutions.

"We certainly have seen reconnaissance activity, and some intrusions, into some of those institutions, especially those that have publicly identified themselves as working on COVID-related research," she said.

Ugoretz said it made sense for institutions working on promising treatments or a potential vaccine to tout their work publicly. However, she said, "The sad flipside is that it kind of makes them a mark for other nation-states that are interested in gleaning details about what exactly they're doing and maybe even stealing proprietary information that those institutions have."

Ugoretz said that state-backed hackers had often targeted biopharmaceutical industry but said "it's certainly heightened during this crisis." She did not name specific countries or identify targeted organizations.

"Medical research organizations and those who work for them should be vigilant against threat actors seeking to steal intellectual property or other sensitive data related to America’s response to the COVID19 pandemic,” said Bill Evanina, Director of the National Counterintelligence and Security Center. “Now is the time to protect the critical research you’re conducting.”

The FBI declined to comment. A spokeswoman for the Office of the Director of National Intelligence had no immediate comment.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.